Skip to main content
⌘K
·
Launch Terminal
Launch Terminal
Home
More
Companies
GLMD
Financials
Full Access with Signal8 Pro,
$49/mo billed annually
.
Get Pro
See what Pro includes
Home
More
Companies
GLMD
Financials
Learn
MCP
API
Support
Cookie Preferences
GLMD (GLMD) Financials: Revenue, Net Income, Cash Flow | Signal8
GLMD (GLMD)
Galmed Pharmaceuticals Ltd.
NASDAQ:GLMD
Healthcare · Biotechnology
Mkt Cap
$4.95M
Float
788K
Shares O/S
1.07M
Inst Own
1.8%
SI
2.5%
Dilution
NASDAQ:GLMD
Healthcare
Mkt Cap
$4.95M
Float
788K
O/S
1.07M
Inst Own
1.8%
SI
2.5%
Dilution
NASDAQ:GLMD
MCap
$4.95M
Float
788K
O/S
1.07M
SI
2.5%
Inst Own
1.8%
Dilution
Overview
Overview
Financials
Financials
Dilution
Dilution
News
News
SEC Filings
Filings
Clinical Trials
Trials
Open on Terminal
Delisting Issues Timeline
Financials Summary
Annual
Quarterly
Debt & Equity
Total Debt
Total Equity
Shares Outstanding
Short Interest
Included in Signal8 Pro
Upgrade to Pro · $49/mo billed annually
Split History
3 splits · 3 reverse
2-year cumulative
1:8
Nasdaq bars a compliance period at 1:250
1:8
Reverse split
Aug 19, 2026
8 shares → 1
1:12
Reverse split
Aug 30, 2024
12 shares → 1
1:15
Reverse split
May 15, 2023
15 shares → 1
Balance Sheet Details
Accounts Receivable
Accounts Payable
Inventory
PP&E (Net)
Goodwill
Intangible Assets
Income Statement
Annual
Quarterly
Balance Sheet
Annual
Quarterly
Cash Flow Statement
Annual
Quarterly
